On the impact of cannabis consumption on traffic safety: a driving simulator study with habitual cannabis consumers.


Journal

International journal of legal medicine
ISSN: 1437-1596
Titre abrégé: Int J Legal Med
Pays: Germany
ID NLM: 9101456

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 13 11 2018
accepted: 17 01 2019
pubmed: 1 2 2019
medline: 25 2 2020
entrez: 1 2 2019
Statut: ppublish

Résumé

To contribute to the ongoing discussion about threshold limits of Δ9-tetrahydrocannabinol (THC) in road traffic, a driving simulator study with 15 habitually cannabis consuming test persons was conducted. Probands were tested on different routes after consumption of a maximum of three cannabis joints, each containing 300 μg THC/kg body weight (sober testing as well as testing directly, 3 and 6 h after cannabis consumption). Accompanying the drives, medical examinations including a blood sampling were performed. Driving faults and distinctive features in the medical examinations were allocated certain penalty points, which were then summed up and evaluated using the ANOVA model. The results showed that very high CIF values > 30 as well as serum THC concentrations > 15 ng/ml significantly increased the number of penalty points, but no direct correlation to the THC concentrations in serum and/or CIF values was detected. Instead, the point in time after cannabis consumption seems to play an important role concerning driving safety: significantly more driving faults were committed directly after consumption. Three hours after consumption, no significant increase of driving faults was seen. Six hours after consumption (during the so-called subacute phase), an increase of driving faults could be noted although not significant. Considering the limitation of our study (e.g. small test group, no placebo test persons, long lasting test situation with possible tiredness), further studies focusing on the time dependant impact of cannabis consumption on road traffic are required.

Identifiants

pubmed: 30701315
doi: 10.1007/s00414-019-02006-3
pii: 10.1007/s00414-019-02006-3
doi:

Substances chimiques

Hallucinogens 0
Dronabinol 7J8897W37S

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1411-1420

Références

Clin Chem. 2013 Mar;59(3):478-92
pubmed: 23220273
Addiction. 2007 Dec;102(12):1910-7
pubmed: 17916224
Am J Addict. 2009 May-Jun;18(3):185-93
pubmed: 19340636
JAMA. 2018 Apr 10;319(14):1433-1434
pubmed: 29582068
Accid Anal Prev. 2010 May;42(3):859-66
pubmed: 20380913
J Anal Toxicol. 2012 Jul;36(6):405-12
pubmed: 22589524
J Psychopharmacol. 2009 May;23(3):266-77
pubmed: 18719045
Drug Alcohol Depend. 2004 Feb 7;73(2):109-19
pubmed: 14725950
BMJ. 2012 Feb 09;344:e536
pubmed: 22323502
Fundam Clin Pharmacol. 2018 Oct;32(5):558-570
pubmed: 29752828
Int J Legal Med. 2016 May;130(3):711-21
pubmed: 26739323

Auteurs

Anne Tank (A)

Institute of Legal Medicine, University Hospital Düsseldorf, Düsseldorf, Germany.

Tobias Tietz (T)

Institute of Mathematics, Heinrich Heine University, Düsseldorf, Germany.

Thomas Daldrup (T)

Institute of Legal Medicine, University Hospital Düsseldorf, Düsseldorf, Germany.

Holger Schwender (H)

Institute of Mathematics, Heinrich Heine University, Düsseldorf, Germany.

Florence Hellen (F)

Department of Psychiatry and Psychotherapy, LVR-Hospital Langenfeld, Langenfeld, Germany.

Stefanie Ritz-Timme (S)

Institute of Legal Medicine, University Hospital Düsseldorf, Düsseldorf, Germany.

Benno Hartung (B)

Institute of Legal Medicine, University Hospital Düsseldorf, Düsseldorf, Germany. benno.hartung@med.uni-duesseldorf.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH